Published in Gene Therapy Weekly, March 13th, 1995
The treatment involves injecting a p53 gene that acts as a brake for cell division into portions of a lung tumor that cannot be removed surgically. The p53 gene attaches to a defective retrovirus which can infect cells but does not reproduce after infection.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.